The effect of caffeine on glucose kinetics in humans-influence of adrenaline

Journal of Physiology

Volumn 569, Issue 1, 2005, Pages 347-355

  Battram, Danielle S ^a   Graham, Terry E ^a   Richter, Erik A ^b   Dela, Flemming ^c  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CAFFEINE; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; LACTIC ACID; PLACEBO;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEART RATE; HUMAN; HUMAN EXPERIMENT; INFUSION; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BLOOD PRESSURE MEASUREMENT; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; HUMAN TISSUE; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; BLOOD GLUCOSE; CAFFEINE; EPINEPHRINE; HUMANS; INSULIN; KINETICS; MALE; METABOLIC CLEARANCE RATE;

EID: 28244463495     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.097444     Document Type: Article

References (37)

1. Abbink-Zandbergen EJ, Vervoort G, Tack CJ, Lutterman JA, Schaper NC & Smits P (1999). The role of adenosine in insulin-induced vasodilation. J Cardiovasc Pharmacol 34, 374-380.
2. Akiba T, Yaguchi K, Tsutsumi K, Nishioka T, Koyama I, Nomura M, Yokogawa K, Moritani S & Miyamoto K (2004). Inhibitory mechanism of caffeine on insulin-stimulated glucose uptake in adipose cells. Biochem Pharmacol 68, 1929-1937.
3. Aldridge A, Aranda JV & Neims AH (1979). Caffeine metabolism in the newborn. Clin Pharmacol Ther 25, 447-453.
4. Altszuler N, De Bodo RC, Steele R & Wall JS (1956). Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187, 15-24.
5. Baron AD, Wallace P & Olefsky JM (1987). In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine. J Clin Endocrinol Metab 64, 889-895.
6. Bessey PQ, Brooks DC, Black PR, Aoki TT & Wilmore DW (1983). Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 94, 172-179.
7. Cherrington AD & Vranic M (1973). Effect of arginine on glucose turnover and plasma free fatty acids in normal dogs. Diabetes 22, 537-543.
8. Clutter WE, Bier DM, Shah SD & Cryer PE (1980). Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 66, 94-101.
9. Crist GH, Xu B, Lanoue KF & Lang CH (1998). Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats. FASEB J 12, 1301-1308.
10. Deibert DC & DeFronzo RA (1980). Epinephrine-induced insulin resistance in man. J Clin Invest 65, 717-721.
11. Divertie GD, Jensen MD, Cryer PE & Miles JM (1997). Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans. Am J Physiol 272, E1130-E1135.
12. Espinal J, Challiss RA & Newsholme EA (1983). Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett 158, 103-106.
13. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G & Wasserman W (2000). Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362, 364-374.
14. 1-13C]palmitic acid. J Clin Invest 67, 1729-1738.
15. Graham TE, Helge JW, MacLean DA, Kiens B & Richter EA (2000). Caffeine ingestion does not alter carbohydrate or fat metabolism in human skeletal muscle during exercise. J Physiol 529, 837-847.
16. Graham TE, Sathasivam P, Rowland M, Marko N, Greer F & Battram D (2001). Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol 79, 559-565.
17. Greer F, Hudson R, Ross R & Graham T (2001). Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 50, 2349-2354.
18. Han DH, Hansen PA, Nolte LA & Holloszy JO (1998). Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47, 1671-1675.
19. Horowitz JF & Klein S (2000). Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol Endocrinol Metab 278, E1144-E1152.
20. Joost HG & Steinfelder HJ (1983). Effects of theophylline on insulin receptors and insulin action in the adipocyte. Mol Cell Biochem 57, 177-183.
21. Karlsson H, Rosenhamer GJ & Wigertz O (1971). One-stage digital correction of distorted dye-dilution curves. Scand J Clin Laboratory Invest 27, 287-291.
22. Keijzers GB, De Galan BE, Tack CJ & Smits P (2002). Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25, 364-369.
23. Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G & Olefsky JM (2002). Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87, 226-234.
24. Lager I, Attvall S, Eriksson BM, von Schenk H & Smith U (1986). Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors. Diabetologia 29, 409-416.
25. Laurent D, Petersen KF, Russell RR, Cline GW & Shulman GI (1998). Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol 274, E130-E138.
26. Lee S, Hudson R, Kilpatrick K, Graham TE & Ross R (2005). Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28, 566-572.
27. Nambi P & Drummond GI (1979). Catecholamine and guanine nucleotide activation of skeletal muscle adenylate cyclase. Biochim Biophys Acta 583, 287-294.
28. Pencek RR, Battram D, Shearer J, James FD, Lacy DB, Jabbour K, Williams PE, Graham TE & Wasserman DH (2004). Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs. J Nutr 134, 3042-3046.
29. Richter EA, Hansen SA & Hansen BF (1988). Mechanisms limiting glycogen storage in muscle during prolonged insulin stimulation. Am J Physiol 255, E621-E628.
30. Sacca L, Vigorito C, Cicala M, Corso G & Sherwin RS (1983). Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans. Am J Physiol 245, E294-E302.
31. Smits P, Boekema P, De Abreu R, Thien T & van't Laar A (1987). Evidence for an antagonism between caffeine and adenosine in the human cardiovascular system. J Cardiovasc Pharmacol 10, 136-143.
32. Smits P, Lenders JW & Thien T (1990). Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther 48, 410-418.
33. Smits P, Straatman C, Pijpers E & Thien T (1991). Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther 50, 529-537.
34. Thong FS, Derave W, Kiens B, Graham TE, Urso B, Wojtaszewski JF, Hansen BF & Richter EA (2002). Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51, 583-590.
35. Thong FS & Graham TE (2002). Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 92, 2347-2352.
36. Vannucci SJ, Nishimura H, Satoh S, Cushman SW, Holman GD & Simpson IA (1992). Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine. Biochem J 288, 325-330.
37. Vergauwen L, Hespel P & Richter EA (1994). Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93, 974-981.